Abstract

The most common presentation of liver and biliary disease is jaundice, and most acute medical teams will encounter several jaundiced patients over time. Some of these patients will be extremely unwell, and a systematic approach will enable all doctors to manage such patients correctly.

Key questions should be addressed during initial assessment:
i. Is the patient critically ill?
ii. Does the patient have fulminant hepatic failure?
iii. Is the jaundice secondary to an intra- or extrahepatic cause?
This article aims to provide a guide to the assessment and management of the acutely jaundiced patient in the emergency setting.
[download-attachments container="div" style="list" dipslay_icon="1" display_count="1" display__size="0"]

References

1. 1.Beckingham IJ, Ryder SD; ABC of diseases of liver, pancreas, and biliary system. Investigation of liver and biliary disease. BMJ 2001; 322: 33–36.
2. Eisen GM, Al-Kawas FH. Editors Dimarino, Benjamin; Gastrointestinal Disease An Endoscopic Approach, ed. 2, SLACK Incorporated; Algorithm for the Investigation of Jaundice 2002: 1377–1383.
3. Whitehead MW, Hainsworth I, Kingham JGC; The causes of obvious jaundice in South West Wales: Perceptions versus reality. Gut 2001; 48(3): 409–413.
4. Björnsson E, Ismael S, Nejdet S, et al; Severe jaundice in Sweden in the new millennium: causes, investigations, treatment and prognosis. Scand J Gastroenterol. 2003; 38(1): 86–94.
5. Hussaini SH, Farrington EA; Idiosyncratic drug-induced liver injury: an overview. Expert Opin Drug Saf. 2007; 6(6): 673–84.
6. Khashab M, Tector AJ, Kwo PY; Epidemiology of acute liver failure. Curr Gastroenterol Rep. 2007; 9(1): 66–73.
7. Andrade RJ, Lucena MI, Fernández MC, et al; Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10- year period. Gastroenterology 2005; 129(2): 512–21.
8. Hussaini SH, O’Brien CS, Despott EJ, et al; Antibiotic therapy: a major cause of drug-induced jaundice in southwest England. European Journal of Gastroenterology & Hepatology 2007; 19(1): 15–20.
9. Neuberger J; Drug-induced jaundice. Baillieres Clin Gastroenterol 1989; 3(2): 447–66.
10. Berry P, Wenden J; Recognition and early management of acute liver failure. Acute Medicine 2005; 4(3): 92–8.
11. Sorbi D, Boynton J, Lindor KD; The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am J Gastroenterol 1999; 94(4): 1018–22.
12. Cassidy WM, Reynolds TB; Serum lactic dehydrogenase in the differential diagnosis of acute hepatocellular injury. Journal of Clinical Gastroenterology 1994; 19(2): 118–21.
13. Salem S, Vas W; Ultrasonography in evaluation of the jaundiced patient. Jn Can Assoc Radiol 1981; 32(1): 30–4.
14. Blackbourne LH, Earnhardt RC, Sistrom CL, et al; The sensitivity and role of ultrasound in the evaluation of biliary obstruction. Am Surg 1994; 60(9): 683–690.
15. Rimola A, Garcia-Tsao G, Navasa M, et al; Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. Journal of Hepatology 2000; 32: 142–53.
16. Arturo A, Bravo MD, Sunil G et al; Current concepts: Liver biopsy. New England Journal of Medicine 2001; 344(7): 495–500.
17. Hultcrantz R, Gabrielsson N; Patients with persistent elevation of aminotransferases: Investigation with ultrasonography, radionucleide imaging and liver biopsy. Journal of Internal Medicine 1993; 233: 7–12.
18. Williams EJ, Green J, Beckingham I et al; Guidelines on the management of common bile duct stones (CBDS). Gut 2008; 57: 1004–1021.
19. Briggs CD, Peterson M; Investigation and management of obstructive jaundice. Surgery 2007; 25(2): 74–80.